Detalhe da pesquisa
1.
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma.
Blood;
140(12): 1378-1389, 2022 09 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35737911
2.
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma.
Int J Mol Sci;
23(24)2022 Dec 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36555330
3.
Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial.
Br J Haematol;
194(2): 378-381, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34002365
4.
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Hematol Oncol;
39(3): 293-303, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33742718
5.
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma.
Ann Hematol;
100(2): 437-443, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33392702
6.
Looking for a needle in the haystack of CLL.
Blood;
141(5): 445-447, 2023 02 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36729546
7.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol;
38(5): 698-704, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32816326
8.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol;
37(4): 368-374, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31325190
9.
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia.
Haematologica;
103(6): 1029-1037, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29567768
10.
Minimal Residual Disease in Indolent Lymphomas: A Critical Assessment.
Curr Treat Options Oncol;
19(12): 71, 2018 11 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30402764
11.
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data.
BMC Bioinformatics;
18(1): 516, 2017 Nov 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29169317
12.
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.
Blood;
122(23): 3759-66, 2013 Nov 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24085766
13.
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance.
Hematol Oncol;
32(3): 133-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24254547
14.
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.
Br J Haematol;
181(5): 693-695, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28369711
15.
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma.
Ann Hematol;
92(11): 1503-11, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23737092
16.
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories.
Front Oncol;
13: 1123029, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36845709
17.
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.
medRxiv;
2023 Dec 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38106151
18.
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing.
EClinicalMedicine;
60: 102016, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37396800
19.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Blood Adv;
7(14): 3764-3774, 2023 07 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37058477
20.
Targeted Locus Amplification as Marker Screening Approach to Detect Immunoglobulin (IG) Translocations in B-Cell Non-Hodgkin Lymphomas.
Methods Mol Biol;
2453: 119-132, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35622324